Trial Profile
Prevenar13(Registried) Suspension Liquid For Injection Drug Use Investigation - Adults Aged 65 Years Or Older
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2023
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions
- Sponsors Pfizer
- 16 Feb 2017 Status changed from recruiting to completed.
- 12 Jan 2017 New trial record